Operator: Good day, everyone, and welcome to Affimed s Fourth Quarter and Full Year 2023 Earnings and Corporate Update Call. At this time all participants are in a listen-only mode.
-Swiss drugmaker Novartis has backed away from its pursuit of Cytokinetics, a person familiar with the matter told Reuters, and the U.S. drug developer s shares were down over 21% in afternoon trade.. -January 11, 2024 at 02:35 pm EST
- MarketScreener
(Reuters) -Swiss drugmaker Novartis has backed away from its pursuit of Cytokinetics, a person familiar with the matter told Reuters, and the U.S. drug .